Long-Term Safety and Efficacy of rFVIIIFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia A
Clinical trial NCT01454739 · COMPLETED
Trial details
- NCT number
- NCT01454739
- Sponsor
- Bioverativ Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2017-10-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.